Elicio Therapeutics annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Elicio Therapeutics Capital Expenditures (CapEx) Growth & History (ELTX)
Elicio Therapeutics's capital expenditures (capex) was $16,000 for fiscal 2025.
View full Elicio Therapeutics company overviewElicio Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $16,000 | −$71,000 | −81.61% |
| 2024 | 2024-12-31 | $87,000 | $21,000 | +31.82% |
| 2023 | 2023-12-31 | $66,000 | −$588,000 | −89.91% |
| 2022 | 2022-12-31 | $654,000 | $272,000 | +71.20% |
| 2021 | 2021-12-31 | $382,000 | $341,000 | +831.71% |
| 2020 | 2020-12-31 | $41,000 | — | — |
Elicio Therapeutics quarterly capital expenditures (capex)
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q3.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $45,000 | $45,000 | — |
| Q3 2024 | 2024-09-30 | $0 | −$45,000 | — |
| Q2 2024 | 2024-06-30 | $42,000 | $38,000 | +950.00% |
| Q1 2024 | 2024-03-31 | $0 | −$17,000 | — |
| Q4 2023 | 2023-12-31 | $0 | −$95,000 | — |
| Q3 2023 | 2023-09-30 | $45,000 | $45,000 | — |
| Q2 2023 | 2023-06-30 | $4,000 | −$555,000 | −99.28% |
| Q1 2023 | 2023-03-31 | $17,000 | $17,000 | — |
| Q4 2022 | 2022-12-31 | $95,000 | $59,000 | +163.89% |
| Q3 2022 | 2022-09-30 | $0 | −$61,000 | — |
| Q2 2022 | 2022-06-30 | $559,000 | $315,000 | +129.10% |
| Q1 2022 | 2022-03-31 | $0 | −$41,000 | — |
| Q4 2021 | 2021-12-31 | $36,000 | $26,000 | +260.00% |
| Q3 2021 | 2021-09-30 | $61,000 | $60,000 | +6000.00% |
| Q2 2021 | 2021-06-30 | $244,000 | $234,000 | +2340.00% |
| Q1 2021 | 2021-03-31 | $41,000 | $21,000 | +105.00% |
| Q4 2020 | 2020-12-31 | $10,000 | — | — |
| Q3 2020 | 2020-09-30 | $1,000 | — | — |
| Q2 2020 | 2020-06-30 | $10,000 | — | — |
| Q1 2020 | 2020-03-31 | $20,000 | — | — |
Elicio Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Elicio Therapeutics's capital expenditures (capex) decreased from $41,000 to $16,000, a change of −$25,000. The latest reported quarter, Q3 2025, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Elicio Therapeutics source filings ↗